Drug intelligence / Profile preview

Corbet XT

Development stage
Unknown
Lead developer
Sinsan Pharmaceuticals
Modality
Small Molecules
Administration
Oral
01

Overview

Corbet XT is a branded generic hematinic combination product marketed by Sinsan Pharmaceuticals. It is primarily indicated for the treatment and prevention of iron deficiency anemia and associated nutritional deficiencies. The formulation typically consists of Carbonyl Iron, Folic Acid (Vitamin B9), and Zinc Sulphate. Carbonyl Iron provides a high concentration of elemental iron with a lower toxicity profile and better gastrointestinal tolerance compared to traditional ferrous salts. Folic Acid is a critical coenzyme for DNA synthesis and the maturation of red blood cells, while Zinc Sulphate serves as an essential trace element and cofactor for numerous enzymes involved in immune function and cellular metabolism. The 'XT' suffix in the Indian pharmaceutical market typically denotes an extended-release formulation, designed to optimize absorption and minimize side effects.

Brand names
Corbet XT
Other names
Carbonyl Iron + Folic Acid + Zinc Sulphate
02

Targets

DNA

Beyond the preview

Go deeper on Corbet XT.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Corbet XT.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call